SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011812
Filing Date
2022-06-17
Accepted
2022-06-17 16:11:35
Documents
12
Period of Report
2022-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K tern-20220616.htm   iXBRL 8-K 63643
  Complete submission text file 0000950170-22-011812.txt   188221

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20220616_lab.xml EX-101.LAB 14564
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20220616.xsd EX-101.SCH 2478
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20220616_pre.xml EX-101.PRE 10683
6 EXTRACTED XBRL INSTANCE DOCUMENT tern-20220616_htm.xml XML 5117
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 221023921
SIC: 2834 Pharmaceutical Preparations